{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T20:43:55Z","timestamp":1770497035009,"version":"3.49.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2000,4,26]],"date-time":"2000-04-26T00:00:00Z","timestamp":956707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2000,4,26]],"date-time":"2000-04-26T00:00:00Z","timestamp":956707200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2000,5,1]]},"DOI":"10.1038\/sj.bmt.1702376","type":"journal-article","created":{"date-parts":[[2002,9,4]],"date-time":"2002-09-04T15:41:57Z","timestamp":1031154117000},"page":"937-942","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Consolidation with a busulfan-containing regimen followed by stem cell transplantation in infants with poor prognosis stage 4 neuroblastoma"],"prefix":"10.1038","volume":"25","author":[{"given":"D","family":"Valteau-Couanet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Benhamou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Vassal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Stambouli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V","family":"Lapierre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Couanet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Lumbroso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2000,4,26]]},"reference":[{"key":"BF1702376_CR1","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1002\/1097-0142(197102)27:2<374::AID-CNCR2820270221>3.0.CO;2-G","volume":"27","author":"AE Evans","year":"1971","unstructured":"Evans AE, D\u2019Angio GJ, Randolp J . A proposed staging for children with neuroblastoma. Children\u2019s Cancer Study Group A Cancer 1971 27: 374\u2013378","journal-title":"Cancer"},{"key":"BF1702376_CR2","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1200\/JCO.1993.11.8.1466","volume":"11","author":"GM Brodeur","year":"1993","unstructured":"Brodeur GM, Pritchard J, Berthold F et al. Revisions of the International Criteria for Neuroblastoma Diagnosis, Staging and Response to Treatment J Clin Oncol 1993 11: 1466\u20131477","journal-title":"J Clin Oncol"},{"key":"BF1702376_CR3","first-page":"584","volume":"47","author":"V Castel Sanchez","year":"1997","unstructured":"Castel Sanchez V, Melero Moreno C, Garcia-Miguel Garcia-Rosados A et al. Stage 4 neuroblastoma en ninos menores de 1 ano Ann Esp Pediatr 1997 47: 584\u2013590","journal-title":"Ann Esp Pediatr"},{"key":"BF1702376_CR4","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1002\/1097-0142(19800301)45:5<833::AID-CNCR2820450502>3.0.CO;2-U","volume":"45","author":"AE Evans","year":"1980","unstructured":"Evans AE, Chatten GJ, D\u2019Angio GJ et al. A review of 17 IV-S neuroblastoma patients at the Children\u2019s hospital of Philadelphia Cancer 1980 45: 833\u2013839","journal-title":"Cancer"},{"key":"BF1702376_CR5","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/mpo.2950220209","volume":"22","author":"C Labreveux de Cervens","year":"1994","unstructured":"Labreveux de Cervens C, Hartmann O, Bonnin F et al. What is the prognostic value of osteomedullary uptake on MIBG scan in neuroblastoma patients under 1 year of age? Med Ped Oncol 1994 22: 107\u2013114","journal-title":"Med Ped Oncol"},{"key":"BF1702376_CR6","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/jnci\/89.5.373","volume":"89","author":"LC Bowman","year":"1997","unstructured":"Bowman LC, Castelberry RP, Cantor A et al. Genetic staging of unresectable or metastatic neuroblastoma in infants: a Pediatric Oncology Group study J Natl Cancer Inst 1997 89: 373\u2013380","journal-title":"J Natl Cancer Inst"},{"key":"BF1702376_CR7","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1023\/A:1005778607661","volume":"31","author":"F Lampert","year":"1997","unstructured":"Lampert F, Christiansen H, Terpe HJ et al. Disseminated neuroblastomas under 1 year of age: cell biology and prognosis J Neuro-Oncol 1997 31: 181\u2013184","journal-title":"J Neuro-Oncol"},{"key":"BF1702376_CR8","first-page":"267 (Abstr. P-4","volume":"31","author":"O Hartmann","year":"1998","unstructured":"Hartmann O, Rubie H, Coze C et al. Stage 4 neuroblastoma in infants: N-myc amplification (NMA) correlates with adverse outcome. SIOP XXX meeting Med Ped Oncol 1998 31: 267 (Abstr. P-41)","journal-title":"Med Ped Oncol"},{"key":"BF1702376_CR9","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1200\/JCO.1998.16.6.2003","volume":"16","author":"KK Matthay","year":"1998","unstructured":"Matthay KK . Stage 4s neuroblastoma: what makes it special? J Clin Oncol 1998 16: 2003\u20132006","journal-title":"J Clin Oncol"},{"key":"BF1702376_CR10","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1200\/JCO.1998.16.6.2007","volume":"16","author":"HM Katzenstein","year":"1998","unstructured":"Katzenstein HM, Bowman L, Brodeur GM et al. Prognostic significance of age, MYCN oncogene amplification, tumor cell ploidy, and histology in 110 infants with stage D(S) neuroblastoma: the Pediatric Oncology Group experience. A Pediatric Oncology Group study J Clin Oncol 1998 16: 2007\u20132017","journal-title":"J Clin Oncol"},{"key":"BF1702376_CR11","doi-asserted-by":"publisher","first-page":"3433","DOI":"10.1200\/JCO.1997.15.12.3433","volume":"12","author":"C Coze","year":"1997","unstructured":"Coze C, Hartmann O, Michon J et al. NB 87 induction protocol for Stage 4 neuroblastoma in children over 1 year of age: a report from the French Society of Pediatrics Oncology J Clin Oncol 1997 12: 3433\u20133440","journal-title":"J Clin Oncol"},{"key":"BF1702376_CR12","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1200\/JCO.1992.10.10.1592","volume":"10","author":"D Frappaz","year":"1992","unstructured":"Frappaz D, Michon J, Hartmann O et al. Etoposide and carboplatin in neuroblastoma: a French Society of Pediatric Oncology phase II study J Clin Oncol 1992 10: 1592\u20131601","journal-title":"J Clin Oncol"},{"key":"BF1702376_CR13","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3109\/08880019409141902","volume":"11","author":"M Avril","year":"1994","unstructured":"Avril M, Hartmann O, Valteau-Couanet D et al. Anti-infective prophylaxis with ceftazidime and teicoplanin in children undergoing high-dose chemotherapy and bone-marrow transplantation Pediatr Hematol Oncol 1994 11: 63\u201373","journal-title":"Pediatr Hematol Oncol"},{"key":"BF1702376_CR14","first-page":"6203","volume":"50","author":"G Vassal","year":"1990","unstructured":"Vassal G, Deroussent A, Hartmann O et al. Dose-dependent neurotoxicity of high-dose busulfan in children: a clinical and pharmacological study Cancer Res 1990 50: 6203\u20136207","journal-title":"Cancer Res"},{"key":"BF1702376_CR15","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1200\/JCO.1988.6.10.1562","volume":"6","author":"SI Bearman","year":"1988","unstructured":"Bearman SI, Appelbaum FR, Buckner CD et al. Regimen-related toxicity in patients undergoing bone marrow transplantation J Clin Oncol 1988 6: 1562\u20131568","journal-title":"J Clin Oncol"},{"key":"BF1702376_CR16","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/hep.1840040121","volume":"4","author":"GB McDonald","year":"1984","unstructured":"McDonald GB, Sharma P, Matthews DE et al. Veno-occlusive disease of the liver after bone marrow transplantation: diagnosis, incidence and predisposing factors Hepatology 1984 4: 116\u2013122","journal-title":"Hepatology"},{"key":"BF1702376_CR17","first-page":"515","volume":"16","author":"D Valteau-Couanet","year":"1995","unstructured":"Valteau-Couanet D, Rubie H, Meresse V et al. Phase I\u2013II study of interleukin-2 after high-dose chemotherapy and autologous bone marrow transplantation in poorly responding neuroblastoma Bone Marrow Transplant 1995 16: 515\u2013520","journal-title":"Bone Marrow Transplant"},{"key":"BF1702376_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/bjc.1977.1","volume":"35","author":"R Peto","year":"1977","unstructured":"Peto R, Pike MC, Armitage P et al. Design and analysis of randomised clinical trials requiring prolonged observations of each patient. II Analysis and examples Br J Cancer 1977 35: 1\u201339","journal-title":"Br J Cancer"},{"key":"BF1702376_CR19","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/0021-9681(78)90043-7","volume":"31","author":"KJ Rothman","year":"1978","unstructured":"Rothman KJ . Estimation of confidence limits for the cumulative probability of survival in life table analysis J Chron Dis 1978 31: 557\u2013560","journal-title":"J Chron Dis"},{"key":"BF1702376_CR20","doi-asserted-by":"publisher","first-page":"185","DOI":"10.2307\/2344317","volume":"135","author":"R Peto","year":"1972","unstructured":"Peto R, Peto J . Asymptotically efficient rank invariant test procedures JR S Stat Soc A 1972 135: 185\u2013207","journal-title":"JR S Stat Soc A"},{"key":"BF1702376_CR21","first-page":"525a (Abstr. 20","volume":"17","author":"KK Matthay","year":"1998","unstructured":"Matthay KK, Harris R, Reynolds CP et al. Improved event-free survival (EFS) for autologous bone marrow transplantation (ABMT) vs chemotherapy in neuroblastoma: a phase III randomized Children\u2019s Cancer Group (CCG) study Proc ASCO 1998 17: 525a (Abstr. 2018)","journal-title":"Proc ASCO"},{"key":"BF1702376_CR22","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1002\/1097-0142(19910315)67:6<1493::AID-CNCR2820670605>3.0.CO;2-#","volume":"67","author":"SR Paul","year":"1991","unstructured":"Paul SR, Tarbell NJ, Korf B et al. Stage IV neuroblastoma in infants Cancer 1991 67: 1493\u20131497","journal-title":"Cancer"},{"key":"BF1702376_CR23","first-page":"111","volume":"318","author":"RC Seeger","year":"1985","unstructured":"Seeger RC, Brodeur GM, Sather H et al. Association of multiple copies of N-myc oncogene with rapid progression of neuroblastomas New Engl J Med 1985 318: 111\u2013116","journal-title":"New Engl J Med"},{"key":"BF1702376_CR24","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1200\/JCO.1991.9.4.581","volume":"9","author":"AT Look","year":"1991","unstructured":"Look AT, Hayes FA, Nitschke R et al. Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study J Clin Oncol 1991 9: 581\u2013591","journal-title":"J Clin Oncol"},{"key":"BF1702376_CR25","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1002\/1097-0142(19920915)70:4+<1685::AID-CNCR2820701607>3.0.CO;2-H","volume":"70","author":"GM Brodeur","year":"1999","unstructured":"Brodeur GM, Azar C, Brother M et al. Neuroblastoma. Effect of genetic factors on prognosis and treatment Cancer 1999 70: 1685\u20131694","journal-title":"Cancer"},{"key":"BF1702376_CR26","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1200\/JCO.1997.15.3.1171","volume":"15","author":"H Rubie","year":"1997","unstructured":"Rubie H, Hartmann O, Michon J et al. N-myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study J Clin Oncol 1997 15: 1171\u20131182","journal-title":"J Clin Oncol"},{"key":"BF1702376_CR27","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/sj.bmt.1701737","volume":"23","author":"O Hartmann","year":"1999","unstructured":"Hartmann O, Valteau-Couanet D, Vassal G et al. Prognostic factors in metastatic neuroblastoma in patients over 1 year of age treated with high-dose chemotherapy and stem cell transplantation: a multivariate analysis of 218 patients treated in a single institution Bone Marrow Transplant 1999 23: 789\u2013795","journal-title":"Bone Marrow Transplant"},{"key":"BF1702376_CR28","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/sj.bjc.6690126","volume":"79","author":"I Boland","year":"1999","unstructured":"Boland I, Vassal G, Morizet J et al. Busulfan is active against neuroblastoma and medulloblastoma xenografts in athymic mice at clinically achievable plasma drug concentrations Br J Cancer 1999 79: 787\u2013792","journal-title":"Br J Cancer"},{"key":"BF1702376_CR29","first-page":"168","volume":"39","author":"O Hartmann","year":"1994","unstructured":"Hartmann O, Valteau-Couanet D, Capelli C et al. High-dose chemotherapy with autologous bone-marrow support in neuroblastoma Sangre 1994 39: 168\u2013171","journal-title":"Sangre"},{"key":"BF1702376_CR30","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1016\/S0959-8049(97)00227-X","volume":"33","author":"O Hartmann","year":"1997","unstructured":"Hartmann O, Valteau-Couanet D, Benhamou E et al. Stage IV neuroblastoma in patients over 1 year at diagnosis: consolidation of poor responders with combined busulfan, cyclophosphamide and melphalan followed by in vitro mafosfamide purged autologous bone marrow transplantation Eur J Cancer 1997 33: 2126\u20132129","journal-title":"Eur J Cancer"},{"key":"BF1702376_CR31","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1200\/JCO.1998.16.3.953","volume":"16","author":"R Ladenstein","year":"1998","unstructured":"Ladenstein R, Philip T, Lasset C et al. Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of 1 year treated with megatherapy and stem-cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumor Registry J Clin Oncol 1998 16: 953\u2013965","journal-title":"J Clin Oncol"},{"key":"BF1702376_CR32","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1200\/JCO.1996.14.9.2417","volume":"14","author":"DO Stram","year":"1996","unstructured":"Stram DO, Matthay K, Leary M et al. Consolidation chemotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent children\u2019s cancer group studies J Clin Oncol 1996 14: 2417\u20132426","journal-title":"J Clin Oncol"},{"key":"BF1702376_CR33","first-page":"106 (Abstr. 469","volume":"17","author":"G Rosti","year":"1996","unstructured":"Rosti G, Philip T, Chauvin F et al. European Group for Blood and Marrow Transplantation (EBMT) registry in solid tumors: 12 years of experience Bone Marrow Transplant 1996 17: (Suppl 1) 106 (Abstr. 469)","journal-title":"Bone Marrow Transplant"},{"key":"BF1702376_CR34","doi-asserted-by":"publisher","first-page":"600","DOI":"10.7326\/0003-4819-126-8-199704150-00002","volume":"126","author":"O Hartmann","year":"1997","unstructured":"Hartmann O, Le Coroller AG, Blaise D et al. Peripheral blood stem cell and bone marrow transplantation for solid tumors and lymphomas: hematologic recovery and costs Ann Intern Med 1997 126: 600\u2013607","journal-title":"Ann Intern Med"},{"key":"BF1702376_CR35","first-page":"135","volume":"10","author":"V Meresse","year":"1992","unstructured":"Meresse V, Hartmann O, Vassal G et al. Risk factors for hepatic veno-occlusive disease after high-dose busulfan containing regimen followed by autologous bone and marrow transplantation: a study of 136 children Bone Marrow Transplant 1992 10: 135\u2013141","journal-title":"Bone Marrow Transplant"},{"key":"BF1702376_CR36","doi-asserted-by":"publisher","first-page":"975","DOI":"10.7326\/0003-4819-128-12_Part_1-199806150-00002","volume":"128","author":"JH Essel","year":"1998","unstructured":"Essel JH, Schroeder MT, Harman GS et al. Ursodiol prophylaxis against hepatic complications of allogeneic bone marrow transplantation Ann Intern Med 1998 128: 975\u2013981","journal-title":"Ann Intern Med"},{"key":"BF1702376_CR37","first-page":"31","volume":"16","author":"JT Slattery","year":"1995","unstructured":"Slattery JT, Sanders JE, Buckner CD et al. Graft rejection and toxicity following bone marrow transplantation in relation to busulfan pharmacokinetics. (published erratum appears in Bone Marrow Transplant 1996; 18: 829) Bone Marrow Transplant 1995 16: 31\u201342","journal-title":"Bone Marrow Transplant"},{"key":"BF1702376_CR38","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/BF00688324","volume":"37","author":"G Vassal","year":"1996","unstructured":"Vassal G, Koscielny S, Challine D et al. Busulfan disposition and hepatic veno-occlusive disease in children undergoing bone marrow transplantation Cancer Chemother Pharmacol 1996 37: 247\u2013253","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF1702376_CR39","first-page":"2363","volume":"14","author":"G Vassal","year":"1994","unstructured":"Vassal G . Pharmacologically guided dose adjustment of busulfan in high-dose chemotherapy regimens: rationale and pitfalls (review) Anticancer Res 1994 14: 2363\u20132370","journal-title":"Anticancer Res"},{"key":"BF1702376_CR40","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/sj.bmt.1701322","volume":"22","author":"US Schuler","year":"1998","unstructured":"Schuler US, Ehrsam M, Schneider A et al. Pharmacokinetics of intravenous busulfan and evaluation of the bioavailability of the oral formulation in conditioning for haematopoietic stem cell transplantation Bone Marrow Transplant 1998 22: 241\u2013244","journal-title":"Bone Marrow Transplant"},{"key":"BF1702376_CR41","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s002800050404","volume":"37","author":"HP Bhagwatwar","year":"1996","unstructured":"Bhagwatwar HP, Phadungpojna S, Chow DS et al. Formulation and stability of busulfan for intravenous administration in high-dose chemotherapy Cancer Chemother Pharmacol 1996 37: 401\u2013408","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF1702376_CR42","first-page":"228 (Abstr. 798","volume":"21","author":"D Valteau-Couanet","year":"1998","unstructured":"Valteau-Couanet D, Kalifa C, Benhamou E et al. Repeated high-dose chemotherapy (HDC) followed by stem cell transplantation (SCT) in young children with poor prognosis medulloblastoma or PNET: tolerance and efficacy Bone Marrow Transplant 1998 21: (Suppl. 1) 228 (Abstr. 798)","journal-title":"Bone Marrow Transplant"},{"key":"BF1702376_CR43","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1056\/NEJM199906243402504","volume":"340","author":"N Bown","year":"1999","unstructured":"Bown N, Cotteril S, Lastowska M et al. Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma New Engl J Med 1999 340: 1954\u20131961","journal-title":"New Engl J Med"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1702376","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1702376.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1702376.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T21:42:23Z","timestamp":1648071743000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1702376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,4,26]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2000,5,1]]}},"alternative-id":["BF1702376"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1702376","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,4,26]]},"assertion":[{"value":"16 August 1999","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2000","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2000","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}